Toxoplasma gondii vaccine

Drug Profile

Toxoplasma gondii vaccine

Alternative Names: Toxoplasmosis vaccine

Latest Information Update: 17 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; National Institutes of Health (USA)
  • Class Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Toxoplasmosis

Most Recent Events

  • 17 Jan 2007 Discontinued - Preclinical for Toxoplasmosis in United Kingdom (unspecified route)
  • 17 Jan 2007 Discontinued - Preclinical for Toxoplasmosis in USA (unspecified route)
  • 09 Apr 2002 An animal study has been added to the Parasitic Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top